Quince Therapeutics, Inc. QNCX
NASDAQ · United States · Health Technology
$29.20-1.71 (-5.53%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -12.31 | -28.02 | +56.1% | $0 | — | +5.3%$32.41→$34.12 |
| Q1 2026 | 2026-05-11 | 57.60 | -52.00 | +210.8% | — | — | -1.6%$25.60→$25.20 |
| Q4 2025 | 2026-04-10 | -152.00 | -45.00 | -237.8% | — | — | +13.7%$24.80→$28.20 |
| Q3 2025 | 2025-11-12 | -50.00 | -40.00 | -25.0% | — | — | -6.1%$358.00→$336.00 |
| Q2 2025 | 2025-08-11 | -65.02 | -46.50 | -39.8% | — | — | — |
| Q1 2025 | 2025-05-13 | -68.00 | -46.00 | -47.8% | — | — | — |
| Q4 2024 | 2025-03-24 | -56.00 | -20.00 | -180.0% | — | — | — |
| Q3 2024 | 2024-11-13 | -26.00 | -20.00 | -30.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.